Tarsus Pharmaceuticals, Inc. (TARS) insider trading.
In Q3 2026, insiders at Tarsus Pharmaceuticals, Inc. reported 17 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 14 sales worth $5.2M.
- Transactions
- 17
- Purchases (P)
- 0
- Sales (S)
- 14
- Net shares, P minus S
- -62,595
- Insiders
- 6
- Last filed
- 2026-09-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Lin Elizabeth Yeu | Officer · Chief Medical Officer | 7 | 0 | 7 |
| Link William J Phd | Director | 4 | 0 | 3 |
| Azamian Bobak R. | Director, Officer · President/CEO and Board Chair | 3 | 0 | 3 |
| Pyott David E I | Director | 1 | 0 | 0 |
| Yarno Wendy L | Director | 1 | 0 | 0 |
| Neervannan Seshadri | Officer · Chief Operating Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Pyott David E I | M (A) | 201 | — | 9,575 | Form 4 |
| 2026-09-15 | Yarno Wendy L | M (A) | 302 | — | 16,956 | Form 4 |
| 2026-09-15 | Link William J Phd | S (D) | 66 | $80.01 | 94,487 | Form 4 |
| 2026-09-15 | Link William J Phd | S (D) | 759 | $79 | 94,553 | Form 4 |
| 2026-09-15 | Link William J Phd | S (D) | 11,675 | $78.33 | 95,312 | Form 4 |
| 2026-09-15 | Link William J Phd | M (A) | 201 | — | 106,987 | Form 4 |
| 2026-09-04 | Neervannan Seshadri | S (D) | 4,564 | $85 | 78,532 | Form 4 |
| 2026-09-04 | Azamian Bobak R. | S (D) | 2,900 | $91.27 | 827,991 | Form 4 |
| 2026-09-04 | Azamian Bobak R. | S (D) | 7,100 | $90.27 | 830,891 | Form 4 |
| 2026-09-04 | Lin Elizabeth Yeu | S (D) | 1,590 | $85 | 3,180 | Form 4 |
| 2026-09-04 | Lin Elizabeth Yeu | S (D) | 1,590 | $90 | 1,590 | Form 4 |
| 2026-09-04 | Lin Elizabeth Yeu | S (D) | 5,387 | $85 | 7,933 | Form 4 |
| 2026-09-04 | Lin Elizabeth Yeu | S (D) | 5,386 | $90 | 2,547 | Form 4 |
| 2026-09-02 | Azamian Bobak R. | S (D) | 10,000 | $80.06 | 837,991 | Form 4 |
| 2026-09-02 | Lin Elizabeth Yeu | S (D) | 1,590 | $80 | 4,770 | Form 4 |
| 2026-09-02 | Lin Elizabeth Yeu | S (D) | 5,387 | $80 | 13,320 | Form 4 |
| 2026-09-01 | Lin Elizabeth Yeu | S (D) | 4,601 | $73.86 | 18,707 | Form 4 |
Transaction codes in this quarter
Get TARS insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1819790&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TARS company page · Tarsus Pharmaceuticals, Inc. on SEC.gov
Questions
Are insiders buying or selling Tarsus Pharmaceuticals, Inc. (TARS)?
In Q3 2026, insiders at Tarsus Pharmaceuticals, Inc. reported 17 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 14 sales worth $5.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Tarsus Pharmaceuticals, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/tars.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.